PHS
CMPS

PFM Health Sciences’s Compass Pathways CMPS Stock Holding History

PFM Health Sciences’s Portfolio CMPS Stock Details CMPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.56M Buy
1,367,099
+587,481
+75% +$3.95M 0.69% 47
2025
Q4 		$5.38M Sell
779,618
-883,218
-53% -$5.39M 0.54% 51
2025
Q3 		$9.53M Sell
1,662,836
-116,423
-7% -$523K 0.73% 40
2025
Q2 		$4.98M Buy
1,779,259
+1,327,992
+294% +$5M 0.42% 41
2025
Q1 		$1.29M Hold
451,267
– – 0.09% 56
2024
Q4 		$1.71M Hold
451,267
– – 0.11% 74
2024
Q3 		$2.84M Sell
451,267
-638,325
-59% -$4.5M 0.16% 62
2024
Q2 		$6.58M Hold
1,089,592
– – 0.33% 53
2024
Q1 		$9.07M Buy
1,089,592
+750,831
+222% +$7.57M 0.43% 56
2023
Q4 		$2.96M Buy
338,761
+285,890
+541% +$1.85M 0.18% 58
2023
Q3 		$391K Sell
52,871
-122,410
-70% -$1.08M 0.02% 72
2023
Q2 		$1.45M Sell
175,281
-70,783
-29% -$601K 0.06% 78
2023
Q1 		$2.44M Sell
246,064
-263,561
-52% -$2.43M 0.11% 70
2022
Q4 		$4.09M Buy
509,625
+111,914
+28% +$1.12M 0.15% 75
2022
Q3 		$4.27M Buy
397,711
+4,947
+1% +$74.1K 0.15% 77
2022
Q2 		$4.25M Buy
+392,764
New +$3.96M 0.16% 77

Other funds holding CMPS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

PFM Health Sciences's CMPS Position: Q1 2026 in Review

PFM Health Sciences increased its Compass Pathways (CMPS) stake by 75% in Q1 2026, buying an estimated $3.95M and bringing the position to 1,367,099 shares worth $7.56M. The position accounts for 0.69% of the portfolio, ranked #47.

PFM Health Sciences first reported a position in CMPS in Q2 2022 and has held it in 16 quarters since. The position peaked at $9.53M in Q3 2025. 194 funds tracked by Wall St. Rank hold CMPS as of Q1 2026.

  • PFM Health Sciences held 1,367,099 shares of Compass Pathways worth $7.56M as of Q1 2026.
  • PFM Health Sciences bought 587,481 Compass Pathways shares in Q1 2026, an estimated $3.95M.
  • Compass Pathways made up 0.69% of PFM Health Sciences's portfolio in Q1 2026, its #47 holding.
  • PFM Health Sciences first reported a position in Compass Pathways in Q2 2022 and has held it in 16 quarters since.
  • PFM Health Sciences's Compass Pathways position peaked at $9.53M in Q3 2025.
  • 194 funds tracked by Wall St. Rank held Compass Pathways as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.